The Spironolactone and Hydrochloroth, cataloged under National Stock Number 6505-01-222-6567, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Barr Laboratories, Inc. Dba Barr Laboratories, Inc Inc. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-222-6567 |
| Primary Part Number | NDC00555-0265-05 |
| Item Name | Spironolactone and Hydrochloroth |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Barr Laboratories, Inc. Dba Barr Laboratories, Inc Inc |
| Status | ACTIVE |
| Primary Container Content Quantity | 1000.000 TABLETS |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 25.000 MILLIGRAMS SPIRONOLACTONE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00555-0265-05 PRIMARY | Barr Laboratories, Inc. Dba Barr Laboratories, Inc Inc (USA) |
| NDC00725-0129-10 PRIMARY | Circa Pharmaceutical Co Inc (USA) |
| Reference | Meaning |
|---|---|
| NDC00014-1011-52 | 5/9 Secondary reference Searle G D and Co |
NSN 6505-01-222-6567 is a Spironolactone and Hydrochloroth, manufactured by Barr Laboratories, Inc. Dba Barr Laboratories, Inc Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-222-6567 has 2 manufacturer part numbers on file: NDC00555-0265-05 (Barr Laboratories, Inc. Dba Barr Laboratories, Inc Inc), NDC00725-0129-10 (Circa Pharmaceutical Co Inc).
Key specifications for NDC00555-0265-05: Primary Container Content Quantity: 1000.000 TABLETS; Primary Container Type: BOTTLE; Active Medicament Medicinal Strength: 25.000 MILLIGRAMS SPIRONOLACTONE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.